All In MedTech

Device Trial Radar · NCT06078865

FX Shoulder Prospective Clinical Study

FX Shoulder Post-Market Follow-Up Clinical Study

Last checked: Nov 20, 2026Latest source record: Feb 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

600

Planned (sponsor's estimate)

Start

Mar 31, 2021

Primary completion

Dec 30, 2031

Study completion Dec 30, 2031

Sponsor

Lead sponsor
FX Shoulder SolutionsNot on our public-company list
Sponsor type
Industry
First posted
Oct 12, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective Multi-Center Registry on study subjects with implanted devices marketed and legally commercialized in the USA by FX Shoulder Solutions.

Conditions

  • Osteoarthritis Shoulder
  • Rotator Cuff Syndrome of Shoulder and Allied Disorders
  • Fracture, Shoulder

Interventions

  • FX Artificial Shoulder ProsthesisDevice

    Humelock II Anatomic Shoulder System, Humelock II Reversible Shoulder System, Humelock Reverse Shoulder System, Humeris Shoulder System, Easytech Anatomical Shoulder System, FXV135 Mini Shoulder System, FXV135 Humelock Shoulder System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. A patient is considered a success at post-operative follow-up based upon the following composite clinical success (CCS):Time frame: 2 years

1 more outcomes with a free account

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • OrthoArizona

    Gilbert, Arizona · Recruiting

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.